{
    "root": "34661206-e37a-6ce7-e063-6394a90aaf85",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "MAXIDEX",
    "value": "20250505",
    "ingredients": [
        {
            "name": "BENZALKONIUM CHLORIDE",
            "code": "F5UM2KM3W7"
        },
        {
            "name": "HYPROMELLOSE, UNSPECIFIED",
            "code": "3NXW29V3WO"
        },
        {
            "name": "SODIUM CHLORIDE",
            "code": "451W47IQ8X"
        },
        {
            "name": "SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM",
            "code": "GR686LBA74"
        },
        {
            "name": "POLYSORBATE 80",
            "code": "6OZP39ZG8H"
        },
        {
            "name": "EDETATE DISODIUM",
            "code": "7FLD91C86K"
        },
        {
            "name": "CITRIC ACID MONOHYDRATE",
            "code": "2968PHW8QP"
        },
        {
            "name": "SODIUM HYDROXIDE",
            "code": "55X04QC32I"
        },
        {
            "name": "WATER",
            "code": "059QF0KO0R"
        },
        {
            "name": "DEXAMETHASONE",
            "code": "7S5I7G3JQL"
        }
    ],
    "indications": "steroid responsive inflammatory conditions palpebral bulbar conjunctiva , cornea , anterior segment globe , allergic conjunctivitis , acne rosacea , superficial punctate keratitis , herpes zoster keratitis , iritis , cyclitis , selected infective conjunctivitides inherent hazard steroid accepted obtain advisable diminution edema inflammation ; corneal injury chemical , radiation , thermal burns , penetration foreign bodies .",
    "contraindications": "shake well using . one two drops topically conjunctival sac ( ) . severe disease , drops may used hourly , tapered discontinuation inflammation subsides . mild disease , drops may used four six times daily . one bottle prescribed initially , prescription refilled without evaluation outlined .",
    "warningsAndPrecautions": "maxidex ® ( dexamethasone ophthalmic suspension ) 0.1 % plastic dispensers : 5 ml ndc 82667-600-05",
    "adverseReactions": "contraindicated acute , untreated bacterial infections ; mycobacterial ocular infections ; epithelial herpes simplex ( dendritic keratitis ) ; vaccinia , varicella , viral diseases cornea conjunctiva ; fungal disease ocular structures ; persons shown hypersensitivity component preparation .",
    "indications_original": "Steroid responsive inflammatory conditions of the palpebral and bulbar conjunctiva, cornea, and anterior segment of the globe, such as allergic conjunctivitis, acne rosacea, superficial punctate keratitis, herpes zoster keratitis, iritis, cyclitis, selected infective conjunctivitides when the inherent hazard of steroid use is accepted to obtain an advisable diminution in edema and inflammation; corneal injury from chemical, radiation, or thermal burns, or penetration of foreign bodies.",
    "contraindications_original": "SHAKE WELL BEFORE USING. One or two drops topically in the conjunctival sac(s). In severe disease, drops may be used hourly, being tapered to discontinuation as the inflammation subsides. In mild disease, drops may be used up to four to six times daily.\n                  Not more than one bottle should be prescribed initially, and the prescription should not be refilled without further evaluation as outlined in PRECAUTIONS above.",
    "warningsAndPrecautions_original": "MAXIDEX\n \n  ®(dexamethasone ophthalmic suspension) 0.1% in plastic dispensers:\n\n \n                  5 mL       NDC 82667-600-05",
    "adverseReactions_original": "Contraindicated in acute, untreated bacterial infections; mycobacterial ocular infections; epithelial herpes simplex (dendritic keratitis); vaccinia, varicella, and most other viral diseases of the cornea and conjunctiva; fungal disease of ocular structures; and in those persons who have shown hypersensitivity to any component of this preparation."
}